9 strategies to lower drug costs, as ranked by public support

Allowing Medicare to negotiate drug prices is the most widely supported initiative to lower high drug costs among Americans, according to a new survey from Kaiser Family Foundation.

The survey, conducted April 17-23, polled a nationally representative sample of 1,171 adults. KFF asked respondents to share their views on nine different policy actions to lower high drug costs.

A majority of respondents favored every policy action except one, which called for patients to pay a larger share if they choose a high-cost drug over a similar, cheaper version, according to the survey.

Here is a breakdown of public support for each action policy by political party.

1. Allowing the federal government to negotiate with drug companies to get a lower price on medications for Medicare recipients

Democrats: 96 percent

Republicans: 92 percent

Independents: 92 percent

2. Making it easier for generic drugs to enter the market to increase competition and reduce costs

Democrats: 84 percent

Republicans: 91 percent

Independents: 91 percent

3. Requiring drug companies to release information on pricing practices to the public

Democrats: 84 percent

Republicans: 84 percent

Independents: 88 percent

4. Limiting the amount drug companies can charge for high-cost treatments, such as hepatitis or cancer drugs

Democrats: 78 percent

Republicans: 79 percent

Independents: 79 percent

5. Creating an independent group that oversees the pricing of prescription drugs

Democrats: 74 percent

Republicans: 71 percent

Independents: 74 percent

6. Allowing Americans to buy prescription drugs imported from Canada

Democrats: 66 percent

Republicans: 75 percent

Independents: 77 percent

7. Allowing Americans to buy prescription drugs from online pharmacies based in Canada

Democrats: 73 percent

Republicans: 59 percent

Independents: 68 percent

8. Eliminating prescription drug ads

Democrats: 59 percent

Republicans: 53 percent

Independents: 59 percent

9. Encouraging people to buy cheaper drugs by requiring them to pay a higher share if they choose a similar, higher cost drug

Democrats: 40 percent

Republicans: 57 percent

Independents: 60 percent

More articles on supply chain:

Poll: GOP prioritizes lower drug prices over reducing government's role in healthcare
10 most-read supply chain stories in Apri
Supply chain tip of the week: Target services — not supplies — for cost savings

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars